On the basis of these findings, here we posited that fibulin-2 drives malignant progression by stabilizing tumor extracellular matrix and tested this hypothesis by performing correlative studies on human lung adenocarcinomas and loss-of-function experiments on KP cells. The gene discussed is FBLN2; the disease is lung adenocarcinoma.